Search filters

List of works by Francesca Chiarini

Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia.

scientific article published on 6 November 2013

Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: involvement of FOXO3a

scientific article

Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting

scientific article published on September 2015

Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics

scientific article

Autophagy in acute leukemias: a double-edged sword with important therapeutic implications

scientific article

Current treatment strategies for inhibiting mTOR in cancer

scientific article

Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling

scientific article published on 20 November 2013

Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia.

scientific article published on 22 May 2012

Enhancing the effectiveness of nucleoside analogs with mTORC1 blockers to treat acute myeloid leukemia patients

scientific article published on 24 May 2013

Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene

scientific article published on 21 January 2017

Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway

scientific article published on 24 October 2016

Increased NGAL (Lnc2) expression after chemotherapeutic drug treatment.

scientific article

K562 cell proliferation is modulated by PLCβ1 through a PKCα-mediated pathway

scientific article published on 6 May 2013

PLCβ1a and PLCβ1b selective regulation and cyclin D3 modulation reduced by kinamycin F during k562 cell differentiation.

scientific article published on March 2015

Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia

scientific article

Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB.

scientific article published on 22 November 2015

Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells

scientific article published on 30 April 2014

Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies

scientific article published on 12 June 2012

Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107)

scientific article published on 15 November 2011

Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (review).

scientific article published on 26 June 2014

Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia

scientific article